An Update of the Medical Treatment of Malignant Endocrine Pancreatic Tumors

Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell Carcinoma

1992 • 948 citations

Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell Carcinoma

1980 • 638 citations

[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation

1991 • 327 citations

Treatment of Metastatic Islet Cell Carcinoma with a Somatostatin Analogue (SMS 201-995)

1987 • 170 citations

Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors

1990 • 165 citations

Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.

1984 • 163 citations

Pancreatic Islet Cell Carcinoma

1973 • 151 citations

Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours

1992 • 137 citations

TREATMENT OF MALIGNANT ENDOCRINE PANCREATIC TUMOURS WITH HUMAN LEUCOCYTE INTERFERON

1986 • 128 citations

Neuroendrocine pancreatic tumours: clinical presentation, biochemical and histopathological findings in 84 patients

1990 • 123 citations

A polyclonal antiserum against chromogranin A and B - a new sensitive marker for neuroendocrine tumours

1990 • 80 citations

Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumours

1990 • 66 citations

Somatostatin and somatostatin analogues in oncology

1989 • 66 citations

Interferons in the management of multiple myeloma.

1988 • 11 citations

Deleted Work

1955 • 0 citations